BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 28682928)

  • 1. Can High-Dose Levetiracetam Be Safe? A Case Report of Prolonged Accidental High-Dose Levetiracetam Administration and Review of the Literature.
    Kartal A
    Clin Neuropharmacol; 2017; 40(5):217-218. PubMed ID: 28682928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam in pediatrics.
    Vigevano F
    J Child Neurol; 2005 Feb; 20(2):87-93. PubMed ID: 15794171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.
    Li S; Cao J; Xiao N; Cai F
    J Child Neurol; 2010 May; 25(5):609-13. PubMed ID: 19779208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term accidental overdose of levetiracetam in an infant.
    Özkale Y; Özkale M; Saygi S; Erol I
    J Child Neurol; 2014 Jul; 29(7):959-61. PubMed ID: 23520362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experience with levetiracetam in childhood epilepsy].
    Neuwirth M; Saracz J; Hegyi M; Paraicz E; Kollár K; Móser J; Rosdy B; Herczegfalvi A; Fogarasi A
    Ideggyogy Sz; 2006 May; 59(5-6):179-82. PubMed ID: 16786712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levetiracetam in children and adolescents with epilepsy and hemiplegic cerebral palsy.
    Harbord MG
    J Paediatr Child Health; 2011 May; 47(5):302-4. PubMed ID: 21244554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective study of the use of levetiracetam in childhood seizure disorders.
    Koukkari MW; Guarino EJ
    J Child Neurol; 2004 Dec; 19(12):944-7. PubMed ID: 15704867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of levetiracetam as an add-on therapy in patients with refractory epilepsy.
    Blais L; Sheehy O; St-Hilaire JM; Bernier G; Godfroid P; LeLorier JJ
    Pharmacoeconomics; 2005; 23(5):493-503. PubMed ID: 15896100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levetiracetam in refractory pediatric epilepsy.
    Wheless JW; Ng YT
    J Child Neurol; 2002 Jun; 17(6):413-5. PubMed ID: 12174960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concerns with antiepileptic drug initiation: safety, tolerability, and efficacy.
    Ferrendelli JA
    Epilepsia; 2001; 42 Suppl 4():28-30. PubMed ID: 11564122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary efficacy of levetiracetam in children.
    Glauser TA; Dulac O
    Epileptic Disord; 2003 May; 5 Suppl 1():S45-50. PubMed ID: 12915341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of high oral doses of levetiracetam in children with epilepsy.
    Obeid M; Pong AW
    Epilepsy Res; 2010 Sep; 91(1):101-5. PubMed ID: 20663645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levetiracetam: treatment in epilepsy.
    Ben-Menachem E
    Expert Opin Pharmacother; 2003 Nov; 4(11):2079-88. PubMed ID: 14596661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical experience with levetiracetam for adults with epilepsy].
    Barcs G; Szucs A
    Ideggyogy Sz; 2007 Jan; 60(1-2):31-4. PubMed ID: 17432091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levetiracetam monotherapy in children with epilepsy.
    Khurana DS; Kothare SV; Valencia I; Melvin JJ; Legido A
    Pediatr Neurol; 2007 Apr; 36(4):227-30. PubMed ID: 17437904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levetiracetam use in pregnancy.
    Longo B; Forinash AB; Murphy JA
    Ann Pharmacother; 2009 Oct; 43(10):1692-5. PubMed ID: 19690219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long-term efficacy and safety of levetiracetam in a tertiary epilepsy centre.
    Kang BS; Moon HJ; Kim YS; Lee ST; Jung KH; Chu K; Lee SK
    Epileptic Disord; 2013 Sep; 15(3):302-10. PubMed ID: 23981665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety profile of levetiracetam.
    Harden C
    Epilepsia; 2001; 42 Suppl 4():36-9. PubMed ID: 11564124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.